GAUDIO, Eugenio
 Distribuzione geografica
Continente #
NA - Nord America 294
EU - Europa 195
AS - Asia 167
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 671
Nazione #
US - Stati Uniti d'America 284
SG - Singapore 120
IT - Italia 83
DE - Germania 42
GB - Regno Unito 22
CN - Cina 21
FI - Finlandia 18
SE - Svezia 13
IN - India 11
BR - Brasile 9
CA - Canada 9
HK - Hong Kong 8
CZ - Repubblica Ceca 5
NL - Olanda 4
EU - Europa 3
FR - Francia 2
PL - Polonia 2
TR - Turchia 2
UA - Ucraina 2
AR - Argentina 1
BD - Bangladesh 1
EE - Estonia 1
ES - Italia 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
MU - Mauritius 1
MX - Messico 1
MY - Malesia 1
PK - Pakistan 1
Totale 671
Città #
Singapore 60
Chandler 48
Munich 31
Ashburn 23
Santa Clara 23
London 21
Turku 16
Catanzaro 14
Vallefiorita 14
Chicago 13
Milan 12
Princeton 12
Lawrence 11
Wilmington 8
Hong Kong 6
Ottawa 6
Luni 5
Olomouc 5
Des Moines 4
Hanover 4
Pune 4
Castrolibero 3
Los Angeles 3
Phoenix 3
Rome 3
The Dalles 3
Washington 3
Assago 2
Bathinda 2
Boardman 2
Cagliari 2
Chennai 2
Cincinnati 2
Dallas 2
Guangzhou 2
Helsinki 2
Leawood 2
Mumbai 2
Padova 2
Paris 2
Peterborough 2
Pontedera 2
San Francisco 2
Seattle 2
Taranto 2
Troina 2
Wan Chai 2
Warsaw 2
Amsterdam 1
Ankara 1
Ann Arbor 1
Aversa 1
Bento Gonçalves 1
Bishkek 1
Brasília 1
Brooklyn 1
Charlotte 1
Chongqing 1
Council Bluffs 1
Cupertino 1
Jonesboro 1
Kryvyi Rih 1
Kuala Lumpur 1
Memphis 1
Montreal 1
Nagold 1
Nairobi 1
New York 1
Norfolk 1
Norwalk 1
Orlando 1
Orobó 1
Parsberg 1
Pingdingshan 1
Port Louis 1
Port Washington 1
Rende 1
San Mateo 1
Santo Antônio do Sudoeste 1
Sapiranga 1
Secaucus 1
Settingiano 1
Shanghai 1
Shaoxing 1
Shenyang 1
Shenzhen 1
Sorocaba 1
Stezzano 1
São Francisco de Itabapoana 1
Torre Del Lago 1
Treviso 1
Valinhos 1
Vancouver 1
Villa Ballester 1
Virginia Beach 1
Várzea Paulista 1
Weihai 1
Totale 449
Nome #
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 52
Pyrrolo[2′,3′:3,4]cyclohepta[1,2- d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types 52
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells. 48
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 44
A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells 41
BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo 40
Discovery of PTPRJ Agonist Peptides That Effectively Inhibit in Vitro Cancer Cell Proliferation and Tube Formation. 40
Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells 37
A novel splice variant of the protein tyrosine phosphatase PTPRJ that encodes for a soluble protein involved in angiogenesis 36
TCL1A interacts with TP63 and enhances the survival of Raji Burkitt lymphoma cell line. 34
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas 30
Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors 30
Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis 28
PTPRJ agonist peptides effectively inhibit in vitro cancer cell proliferation and tube formation 27
Fhit delocalizes Annexin A4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel 26
Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation 25
Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328 24
Transcriptome and computational analysis assess the anti-tubulin activity of [1,2]oxazole derivatives in lymphoma 21
Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas 20
The Tumour Suppressor Fhit Protein Activates C-Raf Ubiquitination and Degradation in Human Melanoma Cells by Interacting with Hsp90 17
null 14
Evaluation of [1,2]oxazolo[5,4-e]isoindoles in lymphoma cells 13
A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers 12
A first-in-class Wiskott-Aldrich syndrome protein (WASp) activator with anti-tumor activity in hematological cancers 11
Totale 722
Categoria #
all - tutte 8.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 2 0 2 0 0 13 23 0 0 6 1 0
2021/202243 0 0 0 12 2 2 0 10 5 7 5 0
2022/2023147 23 8 12 14 14 13 4 13 22 10 10 4
2023/2024127 20 17 3 13 7 44 3 2 1 1 6 10
2024/2025346 32 8 13 7 32 31 26 8 55 5 60 69
Totale 722